Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • China sharply rebukes US over decision to shoot down ‘spy’ balloon
    • Ukraine prepares for renewed Russian offensive
    • Violent end to spy balloon flight dashes chance of US-China reset
    • A problem of logistics: is the US sending Ukraine the wrong tank?
    • Billionaire Koch’s donor network says it opposes Trump’s re-election
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Adani ditched Big Four auditor for UK subsidiaries
      • The sheikh’s empire driving Abu Dhabi’s meteoric stock market rise
      • Baillie Gifford sheds more than £100bn in assets in 2022
      • Indian authorities seek to calm investors after Adani sell-off
      • Electric vehicles defy price war after Ford and Tesla discounts
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Baillie Gifford sheds more than £100bn in assets in 2022
      • Hedge funds rush to unwind bets on falling markets as stocks surge
      • Can the pioneer of blockchain gaming survive the crypto winter?
      • A bipolar currency regime will replace the dollar’s exorbitant privilege
      • Indian authorities seek to calm investors after Adani sell-off
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The case for a land value tax is overwhelming
      • The worst airport in the world
      • Apple blundered when it killed off Dark Sky
      • The Tate ruling is a victory against rubbernecking
      • How the spy balloon popped a US-China rapprochement
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Barclays chief: the life lessons I have discovered during cancer treatment
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • After hours with 10 Foot, London’s most notorious graffiti writer
      • Rugby superstar Siya Kolisi: ‘I’ve got no ego at all’
      • My downshift to deepest Spain
      • Germany grapples with the limits of pacifism
      • Memo to staff: dress fabulously
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Thermo Fisher Scientific Inc

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 11 November, 2020
      Coronavirus pandemic
      Managing a pandemic — Lessons learned in an unfolding crisis

      What steps are needed to improve multinational collaboration on global health challenges?

    • Thursday, 13 August, 2020
      LexMergers & Acquisitions
      Thermo Fisher/Qiagen: follow-up test Premium content

      Dutch group’s shareholders must now scramble to prove they made right move

    • Thursday, 13 August, 2020
      Thermo Fisher’s €10.7bn takeover of Qiagen collapses after investor revolt

      Failure marks a rare example of a deal faltering because Covid-19 improved target’s performance

    • Thursday, 16 July, 2020
      Mergers & Acquisitions
      Thermo Fisher sweetens bid for Qiagen by €1bn after investor criticism

      Hedge fund Davidson Kempner says revised €10.7bn deal still falls short for Dutch group lifted by Covid-19 testing

    • Friday, 10 July, 2020
      Health
      Hedge fund says Thermo Fisher offer undervalues Qiagen amid pandemic

      Davidson Kempner calls valuation 'inadequate' for company that developed Covid-19 test

    • Friday, 10 April, 2020
      Coronavirus pandemic
      Thermo Fisher agrees to supply UK coronavirus tests

      US company’s pledge comes as new lab opens to help meet daily screening target of 100,000

    • Wednesday, 4 March, 2020
      Due Diligence
      IPOs postponed and debt offerings shelved. Coronavirus-induced volatility is gumming up critical sources of capital Premium content

      Welcome to Due Diligence, the FT’s daily deals briefing

    • Tuesday, 3 March, 2020
      Thermo Fisher to buy diagnostics group Qiagen in $11.5bn deal

      Dutch company is developing kits to test for novel coronavirus

    • Monday, 12 June, 2017
      US politics & policy
      Big US pharma dealmaking plunges to five-year low

      Trump’s failure to overhaul American tax code takes toll on M&A  

    • Wednesday, 17 May, 2017
      US & Canadian companies
      Goldman Sachs piles into US leveraged loans market

      Bank pursues business advising M&A buyers as well as sellers

    • Monday, 15 May, 2017
      Pharmaceuticals sector
      Thermo Fisher to buy Patheon in $7.2bn deal
    • Tuesday, 22 July, 2014
      Technology
      Cheap DNA sequencing will transform medical research

      A process that once cost $1bn is likely to fall to tens of dollars within a few years

    • Monday, 6 January, 2014
      Pharmaceuticals sector
      General Electric boosts life sciences division with $1.06bn deal
    • Monday, 15 April, 2013
      US & Canadian companies
      Thermo bid wins Life Technologies auction
    • Monday, 15 April, 2013
      LexUS & Canadian companies
      Life Technologies / Thermo Fisher Scientific

      Combination creates world’s leading scientific test equipment business

    • Monday, 15 April, 2013
      FT AlphavilleIzabella Kaminska
      The (early) Lunch Wrap
    • Monday, 15 April, 2013
      FT AlphavilleHedge funds
      The 6am Cut London
    • Wednesday, 10 April, 2013
      Mergers & Acquisitions
      Trio in $11bn bid for Life Technologies
    • Wednesday, 10 April, 2013
      US equities
      US stocks hit new record high
    • Wednesday, 10 April, 2013
      LexUS & Canadian companies
      Life Technologies: bids under microscope

      Highest offer for science test equipment maker comes with risks

    • Monday, 27 February, 2012
      US & Canadian companies
      Cinven and Goldman to sell Ahlsell stakes
    • Tuesday, 9 August, 2011
      US & Canadian companies
      High-grade debt rides the storm
    • Tuesday, 24 May, 2011
      US & Canadian companies
      Buy-out groups hit record in sales spree
    • Thursday, 19 May, 2011
      US & Canadian companies
      Thermo Fisher to pay €2.47bn for Phadia
    • Monday, 13 December, 2010
      US equities
      Deal flurry not enough to inspire US stocks
    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In